|Articles|March 5, 2012

May we have your opinion?

Please let us know what you are thinking by taking our latest poll and see what your colleagues have to say. Results from our past surveys are here too.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe

Related Content

Dexcom Stelo cleared as first OTC continuous glucose monitor for children

ByPatrick Campbell

June 12th 2026

Weekly review: Mental health concerns, FDA approvals, and more

ByMorgan Ebert, Executive Editor

June 12th 2026

Jeffrey Temple, PhD, discusses new Surgeon General Advisory on screen time use in youth

ByJeffrey R. Temple, PhD

June 12th 2026

Immune endotype linked to poorer recovery in pediatric sepsis, organ failure

ByMorgan Ebert, Executive Editor

June 12th 2026

Handheld optical device detects necrotizing enterocolitis in premature infants before radiographic signs appear

ByMorgan Ebert, Executive Editor

June 11th 2026

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

May we have your opinion?

Related Content

Dexcom Stelo cleared as first OTC continuous glucose monitor for children

Weekly review: Mental health concerns, FDA approvals, and more

Jeffrey Temple, PhD, discusses new Surgeon General Advisory on screen time use in youth

Immune endotype linked to poorer recovery in pediatric sepsis, organ failure

Handheld optical device detects necrotizing enterocolitis in premature infants before radiographic signs appear

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

Handheld optical device detects necrotizing enterocolitis in premature infants before radiographic signs appear

ADA 2026 data highlight pediatric outcomes and treatment satisfaction with Afrezza

Dexcom Stelo cleared as first OTC continuous glucose monitor for children

Weekly review: Mental health concerns, FDA approvals, and more

FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19